Dr. Ricke’s research program encompasses basic and translational sciences as it pertains to the pathogenesis of the lower urinary tract. The synergy of both sciences allows his lab to explore both molecular underlying mechanisms associated with disease progression, but also to pre-clinically treat the same pathways, which may lead to the therapies of tomorrow.
Dr. Ricke’s lab continues to investigate the roles of hormonally regulated paracrine signaling during pathogenesis. They investigate how steroid and EDC signaling function together with other factors in pathogenesis, and how they can translate these findings into clinical trials for the betterment of mankind.
